$PHIL
PHI GROUP INC

2023 Q2 Form 10-Q Financial Statement

#000149315223018544 Filed on May 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $0.00 $5.000K
YoY Change 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin -$248.3K $294.5K
YoY Change 133.34%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $216.6K $307.1K $294.5K
YoY Change 4.25% 133.34%
Operating Profit -$307.1K -$289.5K
YoY Change 6.05%
Interest Expense -$112.0K $377.0K -$89.00K
YoY Change -523.61% 192.19%
% of Operating Profit
Other Income/Expense, Net -$1.064M -$1.472M -$1.674M
YoY Change -12.08% 210.08%
Pretax Income -$1.392M -$2.052M
YoY Change 196.8%
Income Tax
% Of Pretax Income
Net Earnings -$1.392M -$1.779M -$2.052M
YoY Change -13.33% 196.8%
Net Earnings / Revenue -41047.0%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$72.47
COMMON SHARES
Basic Shares Outstanding 37.06B shares 33.65B shares 28.32B shares
Diluted Shares Outstanding 34.02B shares 28.32B shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.19K $4.113M
YoY Change 387.66%
Cash & Equivalents $19.77K $39.42K $23.59K
Short-Term Investments $420.00 $4.089M
Other Short-Term Assets $241.4K $242.4K $233.1K
YoY Change -33.92% 4.0% -12.16%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $261.6K $282.3K $4.346M
YoY Change -39.69% -93.5% 291.96%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $32.60K $947.5K
YoY Change 18849.0%
Other Assets
YoY Change
Total Long-Term Assets $32.60K $37.60K $947.5K
YoY Change -9.84% -96.03% 18849.0%
TOTAL ASSETS
Total Short-Term Assets $261.6K $282.3K $4.346M
Total Long-Term Assets $32.60K $37.60K $947.5K
Total Assets $294.2K $319.9K $5.293M
YoY Change -37.4% -93.96% 375.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $616.2K $615.4K $540.4K
YoY Change 0.07% 13.89% 29.34%
Accrued Expenses $1.485M $1.262M $849.8K
YoY Change 59.47% 48.46% -71.81%
Deferred Revenue $1.079M $760.4K
YoY Change 62.16%
Short-Term Debt $1.165M $814.3K $1.428M
YoY Change -42.96% 95.55%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.516M $8.606M $6.239M
YoY Change 21.43% 37.94% -26.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.516M $8.606M $6.239M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $8.516M $8.606M $6.239M
YoY Change 21.43% 37.94% -26.58%
SHAREHOLDERS EQUITY
Retained Earnings -$77.32M -$75.93M
YoY Change 7.81%
Common Stock $72.19M $70.29M
YoY Change 9.67%
Preferred Stock
YoY Change
Treasury Stock (at cost) $44.17K $44.17K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$8.222M -$8.287M -$946.4K
YoY Change
Total Liabilities & Shareholders Equity $294.2K $319.9K $5.293M
YoY Change -37.4% -93.96% 375.27%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.392M -$1.779M -$2.052M
YoY Change -13.33% 196.8%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.018M $270.0K
YoY Change -211.77%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $506.4K -$137.2K
YoY Change
Cash From Investing Activities $506.4K -$137.2K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 534.8K -162.9K
YoY Change -161.69%
NET CHANGE
Cash From Operating Activities -1.018M 270.0K
Cash From Investing Activities 506.4K -137.2K
Cash From Financing Activities 534.8K -162.9K
Net Change In Cash 23.63K -30.15K
YoY Change -233.76%
FREE CASH FLOW
Cash From Operating Activities -$1.018M $270.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000704172
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 PHIL Common Stock To Be Issued
CommonStockToBeIssued
usd
CY2022Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2023#InvestmentAdvisoryManagementAndAdministrativeServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2023#InvestmentAdvisoryManagementAndAdministrativeServiceMember
CY2023Q1 us-gaap Revenues
Revenues
usd
PHIL Adjustment For Funds In Transit
AdjustmentForFundsInTransit
usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
PHIL Increase Decrease In Subfund Obligations And Contingency Commitments
IncreaseDecreaseInSubfundObligationsAndContingencyCommitments
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
PHIL Proceeds From Issuance Of Common Stock To Be Issued
ProceedsFromIssuanceOfCommonStockToBeIssued
usd
PHIL Proceeds From Crypto Currencies And Security Tokens
ProceedsFromCryptoCurrenciesAndSecurityTokens
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38255-NY
dei Entity Registrant Name
EntityRegistrantName
PHI GROUP, INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0114535
dei Entity Address Address Line1
EntityAddressAddressLine1
2323 Main Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92614
dei City Area Code
CityAreaCode
714
dei Local Phone Number
LocalPhoneNumber
793-9227
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
PHIL
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37059293090 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39424 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67896 usd
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
420 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
546 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
242420 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
365360 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
282264 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
433802 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
37601 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
36161 usd
CY2023Q1 us-gaap Assets
Assets
319865 usd
CY2022Q2 us-gaap Assets
Assets
469963 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
615405 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
615805 usd
CY2023Q1 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1683459 usd
CY2022Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1574775 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1261565 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
931417 usd
CY2023Q1 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1044461 usd
CY2022Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
676888 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
572500 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
756250 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1045210 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1077218 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
760434 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
665434 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1623460 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
715677 usd
CY2023Q1 us-gaap Liabilities
Liabilities
8606494 usd
CY2022Q2 us-gaap Liabilities
Liabilities
7013465 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Preferred Stock Including Additional Paid In Capital
PreferredStockIncludingAdditionalPaidInCapital
2440 usd
CY2022Q2 us-gaap Preferred Stock Including Additional Paid In Capital
PreferredStockIncludingAdditionalPaidInCapital
2440 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36349939124 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36349939124 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31429380453 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31429380453 shares
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,500 reverse split
CY2022 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,500 reverse split
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
36349939 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
31429381 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33943377 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
34394912 usd
CY2023Q1 PHIL Common Stock To Be Issued
CommonStockToBeIssued
396000 usd
CY2023Q1 PHIL Common Stock To Be Cancelled
CommonStockToBeCancelled
35500 usd
CY2022Q2 PHIL Common Stock To Be Cancelled
CommonStockToBeCancelled
35500 usd
CY2023Q1 PHIL Treasury Stock Common And Preferred Shares
TreasuryStockCommonAndPreferredShares
484767 shares
CY2022Q2 PHIL Treasury Stock Common And Preferred Shares
TreasuryStockCommonAndPreferredShares
484767 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
44170 usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
44170 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75932642 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71717973 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2966071 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-572591 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8286628 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-6543502 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
319865 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
469963 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30000 usd
CY2022Q1 us-gaap Revenues
Revenues
5000 usd
us-gaap Revenues
Revenues
25000 usd
us-gaap Revenues
Revenues
30000 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
90000 usd
CY2022Q1 us-gaap Salaries And Wages
SalariesAndWages
90000 usd
us-gaap Salaries And Wages
SalariesAndWages
270000 usd
us-gaap Salaries And Wages
SalariesAndWages
273040 usd
CY2023Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
157462 usd
CY2022Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
180400 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
436226 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
15114627 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59603 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24142 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
102819 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
108943 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
307065 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
294542 usd
us-gaap Operating Expenses
OperatingExpenses
809045 usd
us-gaap Operating Expenses
OperatingExpenses
15496610 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-307065 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-289542 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-784045 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15466610 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
377009 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
89002 usd
us-gaap Interest Expense
InterestExpense
822905 usd
us-gaap Interest Expense
InterestExpense
1041943 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1094638 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1673810 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2609718 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2095610 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1471647 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1762812 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3432624 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3137553 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1778713 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2052354 usd
us-gaap Net Income Loss
NetIncomeLoss
-4216669 usd
us-gaap Net Income Loss
NetIncomeLoss
-18604163 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34018394095 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28319126230 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34018394095 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28319126230 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34018394095 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28319126230 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34018394095 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28319126230 shares
us-gaap Net Income Loss
NetIncomeLoss
-4216669 usd
us-gaap Net Income Loss
NetIncomeLoss
-18604163 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1485011 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
402280 usd
PHIL Stock Issuance For Services And Cancellation Of Debts
StockIssuanceForServicesAndCancellationOfDebts
3793473 usd
PHIL Stock Issuance For Services And Cancellation Of Debts
StockIssuanceForServicesAndCancellationOfDebts
18419645 usd
PHIL Adjustment For Funds In Transit
AdjustmentForFundsInTransit
2500 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-113440 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-400 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-68163 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
224793 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
150083 usd
PHIL Increase Decrease In Subfund Obligations And Contingency Commitments
IncreaseDecreaseInSubfundObligationsAndContingencyCommitments
108684 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
95000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-50000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1357190 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-554878 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
502798 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-502798 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
251800 usd
PHIL Proceeds From Issuance Of Common Stock To Be Issued
ProceedsFromIssuanceOfCommonStockToBeIssued
396000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
680919 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
885924 usd
PHIL Proceeds From Crypto Currencies And Security Tokens
ProceedsFromCryptoCurrenciesAndSecurityTokens
100000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1328719 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
985924 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-28471 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-71752 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67896 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
95344 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39424 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23592 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-6543502 usd
PHIL Stock Issued During Value Conversions Of Promissory Notes
StockIssuedDuringValueConversionsOfPromissoryNotes
233614 usd
PHIL Stock Issued During Value Exercise Of Warrants
StockIssuedDuringValueExerciseOfWarrants
2395080 usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
545710 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6881906 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6881906 usd
CY2023Q1 PHIL Stock Issued During Value Conversions Of Promissory Notes
StockIssuedDuringValueConversionsOfPromissoryNotes
1576175 usd
CY2023Q1 PHIL Stock Issued During Value Conversions Of Promissory Notes
StockIssuedDuringValueConversionsOfPromissoryNotes
1576175 usd
CY2023Q1 PHIL Stock Issued During Value Shares Issued For Cash
StockIssuedDuringValueSharesIssuedForCash
624865 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
185000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8286628 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8286628 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_802_eus-gaap--NatureOfOperations_zm6obMsPsp5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">NOTE 1</span></b> – <b><span id="xdx_82D_zkjbgSixU6y8">NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTRODUCTION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI Group, Inc. (n/k/a Philux Global Group Inc) (the “Company” or “PHI”) (<span style="text-decoration: underline">www.philuxglobal.com</span>) is primarily engaged in mergers and acquisitions, advancing PHILUX Global Funds, SCA, SICAV-RAIF, a “Reserved Alternative Investment Fund” (“RAIF”) under the laws of Luxembourg, and developing the Asia Diamond Exchange in Vietnam. Besides, the Company provides corporate finance services, including merger and acquisition advisory and consulting services for client companies through our wholly owned subsidiary PHILUX Capital Advisors, Inc. (formerly PHI Capital Holdings, Inc.) (www.philuxcapital.com<span style="text-decoration: underline">)</span> and invests in selective industries and special situations aiming to potentially create significant long-term value for our shareholders. PHILUX Global Funds intends to include a number of sub-funds for investment in select growth opportunities in the areas of agriculture, renewable energy, real estate, infrastructure, and the Asia Diamond Exchange in Vietnam.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BACKGROUND</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Originally incorporated on June 8, 1982 as JR Consulting, Inc., a Nevada corporation, the Company applied for a Certificate of Domestication and filed Articles of Domestication to become a Wyoming corporation on September 20, 2017. In the beginning, the Company was foremost engaged in mergers and acquisitions and had an operating subsidiary, Diva Entertainment, Inc., which operated two modeling agencies, one in New York and one in California. In January 2000, the Company changed its name to Providential Securities, Inc., a Nevada corporation, following a business combination with Providential Securities, Inc., a California-based financial services company. In February 2000, the Company then changed its name to Providential Holdings, Inc. In October 2000, Providential Securities withdrew its securities brokerage membership and ceased its financial services business. Subsequently, in April 2009, the Company changed its name to PHI Group, Inc. From October 2000 to October 2011, the Company and its subsidiaries were engaged in various transactions in connection with mergers and acquisitions advisory and consulting services, real estate and hospitality development, mining, oil and gas, telecommunications, technology, healthcare, private equity, and special situations. In October 2011, the Company discontinued the operations of Providential Vietnam Ltd., Philand Ranch Limited, a United Kingdom corporation (together with its subsidiaries Philand Ranch - Singapore, Philand Corporation - US, and Philand Vietnam Ltd. - Vietnam), PHI Gold Corporation (formerly PHI Mining Corporation, a Nevada corporation), and PHI Energy Corporation (a Nevada corporation), and mainly focused on acquisition and development opportunities in energy and natural resource businesses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is currently focused on PHILUX Global Funds, SCA, SICAV-RAIF by launching Philux Global Select Growth Fund and potentially other sub-funds for investment in real estate, renewable energy, infrastructure, agriculture, healthcare and the Asia Diamond Exchange in Vietnam. In addition, PHILUX Capital Advisors, Inc. (formerly Capital Holdings, Inc.), a wholly owned subsidiary of the Company, continues to provide corporate and project finance services, including merger and acquisition (M&amp;A) advisory and consulting services for U.S. and international companies. The Company has also formed Philux Global Advisors, Inc. to serve as the investment advisor to PHILUX Global Funds and other potential fund clients in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had signed agreements to acquire majority equity interests in Kota Construction LLC and Kota Energy Group LLC (“KOTA”) which are engaged in solar energy business (<span style="text-decoration: underline">https://www.kotasolar.com</span>), Tin Thanh Group, a Vietnamese joint stock company (www.tinthanhgroup.vn) (“TTG”) and Van Phat Dat Joint Stock Company, a Vietnamese joint stock company. Whereas the scheduled closing dates for the KOTA and TTG transactions already expired, the Company has continued to discuss with these companies and intends to renegotiate an revised agreement for acquisition with them when the Company successfully closes one or more of the pending financing and investment management agreements with certain lenders and investor groups. In addition, the Company is in the process of amending the Purchase and Sale Agreement that was originally signed on January 18, 2022 with Five-Grain Treasure Spirits Co., Ltd., a Chinese baiju distiller, to collaborate in launching American-made baiju products through Empire Spirits, Inc., a subsidiary of the Company. The Company will also relocate CO2-1-0 (CARBON) Corp., a subsidiary of the Company engaged in carbon emission mitigation using blockchain and crypto technologies, to the United Arab Emirates. These activities are disclosed in greater detail elsewhere in this report. No assurances can be made that the Company will be successful in achieving its plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BUSINESS STRATEGY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI’s strategy is to:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Identify, build, acquire, commit and deploy valuable resources with distinctive competitive advantages;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Identify, evaluate, acquire, participate and compete in attractive businesses that have large, growing market potential;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Build an attractive investment that includes points of exit for investors through capital appreciation or spin-offs of business units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zW8yMwl0KGif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zjMjeTEFR7H3">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
420 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zl49rmNbHmOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_ziLkIF25BO2e">RISKS AND UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company is subject to certain risks and uncertainties. The Company provides its service and receives marketable securities upon execution of transactions. Consequently, the value of the securities received from customers can be affected by economic fluctuations and each customer’s business growth. The actual realized value of these securities could be significantly different than recorded value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
420 usd
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
420 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
546 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
37601 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
36161 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
615405 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
615805 usd
CY2023Q1 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1683459 usd
CY2022Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1574775 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1261565 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
931417 usd
CY2023Q1 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1044461 usd
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
185000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36349939124 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36349939124 shares
CY2022Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
676888 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
572500 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
756250 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1045210 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1077218 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
760434 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
665434 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1623460 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
715677 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8606494 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7013465 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1261565 usd
CY2023Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
943842 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
308723 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
814348 usd
us-gaap Professional Fees
ProfessionalFees
660434 usd
CY2023Q1 us-gaap Deposits
Deposits
100000 usd
CY2023Q1 us-gaap Other Commitment
OtherCommitment
96840 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1045210 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1077218 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1045210 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1077218 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1045210 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1077218 usd
CY2015Q1 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
1000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0118 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.393 pure
CY2023Q1 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
5747 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
484767 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
44170 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1909744449 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
609309245 shares
CY2022Q2 PHIL Annual Revenues
AnnualRevenues
5500000000 usd
CY2023Q1 PHIL Common Stock To Be Issued
CommonStockToBeIssued
396000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75932642 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8286628 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1778713 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2052354 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001493152-23-018544-index-headers.html Edgar Link pending
0001493152-23-018544-index.html Edgar Link pending
0001493152-23-018544.txt Edgar Link pending
0001493152-23-018544-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
phil-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
phil-20230331_def.xml Edgar Link unprocessable
phil-20230331_lab.xml Edgar Link unprocessable
phil-20230331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
phil-20230331_cal.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending